Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Código QR

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Guardado en:

Detalles Bibliográficos
Autores principales:	Marco Rossato, Angelo Di Vincenzo
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/3fae216483b24c21bb8e521c10d63e6f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Bin Tu, et al.
Publicado: (2021)

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
por: Maki Komiyama, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Eliecer Coto, et al.
Publicado: (2021)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Jin-Ying Fang, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.
por: Jia Yao, et al.
Publicado: (2021)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
por: Meng-Yuan Liu, et al.
Publicado: (2020)

Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis
por: Mohitosh Biswas, et al.
Publicado: (2021)

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
por: Giuseppe MC Rosano, et al.
Publicado: (2019)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Davide Stolfo, et al.
Publicado: (2019)

Comparative efficacy and predictive value of fixed combination of amlodipine and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in patients with coronary heart disease, post-infarction cardiosclerosis and hypertension
por: M. M. Dolzhenko, et al.
Publicado: (2021)

Effect of Angiotensin Receptor Blocker and Angiotensin Converting Enzyme Inhibitor on Kidney Function and Blood Potassium Level in Indonesian Type 2 Diabetes Mellitus with Hypertension: A Three-Month Cohort Study
por: Puspita FM, et al.
Publicado: (2021)

Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia
por: Selçuk Görmez, et al.
Publicado: (2021)

The role of doctors in smoking cessation: evidence from the Cochrane Library
por: Tim Lancaster
Publicado: (2021)

A systematic review and meta-analysis of angiotensin-converting enzyme inhibitor use and psoriasis incidence
por: Gonjin Song, et al.
Publicado: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
por: Miklós Fagyas, et al.
Publicado: (2014)

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
por: Pankaj Jariwala, et al.
Publicado: (2021)

New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
por: Miklós Fagyas, et al.
Publicado: (2014)

Coronavirus Disease 2019 and Cardiac Arrhythmias
por: Antoni Martínez-Rubio, et al.
Publicado: (2020)

Electrophysiology in the Era of Coronavirus Disease 2019
Publicado: (2020)

Coronavirus disease 2019 and flight safety
por: Sevgi Özcan
Publicado: (2021)

Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
por: Xiao-Yu Xin, et al.
Publicado: (2021)

Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
por: Fengxia Xiao, et al.
Publicado: (2012)

Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex
por: Alberto Bartolomé, et al.
Publicado: (2021)

Coronavirus Disease 2019: Where are we and Where are we Going? Intersections Between Coronavirus Disease 2019 and the Heart
por: Emilia D’Elia, et al.
Publicado: (2020)

Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
por: Berkay Ekici, et al.
Publicado: (2021)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

Treatment of Coronavirus Disease 2019: Shooting in the Dark
por: Juan Tamargo
Publicado: (2020)

Mechanisms of Myocardial Injury in Coronavirus Disease 2019
por: Aniket S Rali, et al.
Publicado: (2020)

Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers
por: Jordi Heijman, et al.
Publicado: (2021)

Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
por: Seung-Hwa Lee, et al.
Publicado: (2021)

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
por: Ya-Feng Li, et al.
Publicado: (2012)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Brittany L. Fowler, et al.
Publicado: (2021)

The Chemical Compounds of Flacourtia rukam Leaves and Their Inhibition of Angiotensin-converting Enzyme (ACE) Activity
por: Muharni Muharni, et al.
Publicado: (2021)

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management
por: Mahmoud Abdelnabi, et al.
Publicado: (2020)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Rocco A Montone, et al.
Publicado: (2020)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

Acute myocarditis after coronavirus disease 2019 vaccination
por: Beuy Joob, et al.
Publicado: (2021)